Effects of Gushukang for postmenopausal osteoporosis: A protocol for systematic review and meta-analysis

BACKGROUND: Postmenopausal osteoporosis (PMO) is one of the most common systemic bone diseases with a high risk of fracture. Traditional herbal formula Gushukang (GSK) has been used to treat PMO. However, there is no systematic review related to GSK for PMO. The object of this work is to evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guangwei, Huo, Liwei, Chen, Guocai, He, Huayong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337472/
https://www.ncbi.nlm.nih.gov/pubmed/32629684
http://dx.doi.org/10.1097/MD.0000000000020908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337472/
https://www.ncbi.nlm.nih.gov/pubmed/32629684
http://dx.doi.org/10.1097/MD.0000000000020908

Ejemplares similares